Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research Snapshot

One-page overview of trials, participants, papers, and research networks.

Clinical Guidelines

Trial-anchored manuals and protocol guidance with competency mapping.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

AskBeta
Pricing

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.

Home/Research/DMT/Creativity

DMT for Creativity

5 papers and 0 clinical trials exploring dmt as a treatment for creativity.

CompoundTryptamine

DMT

A powerful, short-acting tryptamine psychedelic found in many botanical sources, known for rapid onset and intense subjective experiences.

Full DMT profile
Indication300 million adults struggling with creative blocks globally.

Creativity

Psychedelics have emerged as potential enhancers of creativity, influencing both divergent and convergent thinking processes. Current research indicates their capacity to disrupt cognitive rigidity and promote innovative thought patterns, warranting further exploration into their therapeutic and recreational applications.

Full Creativity profile

Academic Research

5 papers
Paywallindividual

Ayahuasca-inspired DMT/harmine formulation alters creative thinking dynamics during artistic creation

In a double‑blind, placebo‑controlled within‑subject study using an ecologically valid painting task, an ayahuasca‑inspired DMT/harmine formulation impaired convergent thinking (particularly in participants with higher baseline reasoning) and showed trend‑level reductions in divergent fluency and elaboration. At the process level both DMT/HAR and harmine reduced incubation‑related transitions, while DMT/HAR uniquely decreased transitions from incubation to illumination, indicating psychedelics alter the dynamic pathways to creative insight and that subjective altered meaning and insightfulness selectively predict divergent but not convergent outcomes.

Published
August 16, 2025
Journal
Journal of Psychopharmacology
Authors
Suay, D., Aicher, H. D., Singer, B., Mueller, M. J., Jelusic, A., Calzaferri, L., Springfeld, P., Dornbierer, D. A., Scheidegger, M.
Paywallindividual

Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users

In ritualistic Santo Daime users, ayahuasca produced pronounced alterations in consciousness—especially oceanic boundlessness, visual restructuralization and ego dissolution—that correlated with peak serum DMT concentrations. Standard measures of mental imagery were largely unchanged (though perspective shifts and cognitive flexibility correlated with DMT), and peak alkaloid levels did not track dose, suggesting DMT primarily drives the acute phenomenology while long‑term use may attenuate imagery effects.

Published
September 1, 2023
Journal
Journal of Cognitive Neuroscience
Authors
Ramaekers, J. G., Mallaroni, P., Kloft, L., Reckweg, J., Toennes, S. W., van Oorsouw, K., Mason, N. L.
Paywallmeta

The risk of chronic psychedelic and MDMA microdosing for valvular heart disease

This review (2023) covers in vitro, animal, and clinical studies to assess the potential risk of valvular heart disease (VHD) from microdosing psychedelic substances, focusing on LSD, psilocybin, mescaline, DMT, and MDMA due to their interaction with the serotonin 5-HT2B receptor. Findings show that all these compounds, except mescaline (due to low potency), were partial agonists at the 5-HT2B receptor. While safety margins from typical microdoses were greater than known valvulopathogens, there remains a potential risk. No studies directly evaluated VHD risk for the four psychedelics, but some evidence suggests chronic ingestion of full doses of MDMA might be linked to VHD.

Published
August 12, 2023
Journal
Journal of Psychopharmacology
Authors
Tagen, M., Mantuani, D., Van Heerden, L., Holstein, A., Klumpers, L. E., Knowles, R.
Paywallmeta

New insights into the clinical and nonclinical effects of psychedelic substances: An integrative review.

This review (2022) explores the potential of psychedelics in treating mental health disorders, their short- and long-term effects on recreational users, and the neurological and cognitive processes responsible for their effects using the most up to date research. The positive findings of psilocybin for depression (MDD) and anxiety are highlighted. The mystical experience (MEQ) also plays a large role, but individual differences (for whom does it work) are still not well examined.

Published
May 23, 2022
Journal
European Psychologist
Authors
Forstmann, M., Sagioglou, C.
Open Accessmeta

N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function

This review (2018) presents the historical research into DMT, focussing on its biosynthesis, metabolism, sites of action, methods of detection, and potential physiological and therapeutic roles. The author proposes several areas for further research and highlights the need to resolve the role of endogenous DMT.

Published
August 6, 2018
Journal
Frontiers in Neuroscience
Authors
Barker, S.

Clinical Trials

0 trials

No clinical trials have been tagged with both DMT and Creativity yet.

Trials are continuously being added as new studies are registered.

Explore further

Search all DMT papers Search all Creativity trials Full DMT profile Full Creativity profile